Abstract
After more than 20 years from its discovery, MECP2 roles are far from the fully understanding. MeCP2 binds the genome globally, with the need of a single, methylated CG and is enriched in heterochromatic foci. Early hypothesis proposed it as a generalized repressor and modulator of genome architecture that keeps down the transcriptional noise. Its modulation of L1 retrotransposition and the regulation of pericentric heterochromatin condensation might be conceivably associated with this function. Interestingly, MECP2 is mutated in the paradigmatic chromatin disease Rett syndrome, an X linked neurodevelopmental disease affecting females. This highlighted a different function of MECP2, as repressor of downstream genes and the identification of few downstream genes corroborated this hypothesis. Rather recently, however, with the help of high throughput technologies and a number of appropriate mouse models finely dissecting MECP2 functional domains, new and somehow unexpected roles for MECP2 have been highlighted. Expression profiling studies of specific brain areas support a role of MeCP2 not only as a transcriptional silencer but also as activator of gene expression. Beyond its binding to DNA, MeCP2 is also able to influence alternative splicing, promoting inclusion of hypermethylated exons in alternatively spliced transcripts. MeCP2 has been also found to bind non CG methylated residues in brain. Overall, MECP2 appears to be a multifunctional protein, exquisitely adapted to support the functional complexity of the brain.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agarwal, N., Hardt, T., Brero, A., Nowak, D., Rothbauer, U., Becker, A., Leonhardt, H., Cardoso, M.C.: Mecp2 interacts with Hp1 and modulates its heterochromatin association during myogenic differentiation. Nucleic Acids Res. 35, 5402–5408 (2007)
Agarwal, N., Becker, A., Jost, K.L., Haase, S., Thakur, B.K., Brero, A., Hardt, T., Kudo, S., Leonhardt, H., Cardoso, M.C.: MeCP2 Rett mutations affect large scale chromatin organization. Hum. Mol. Genet. 20, 4187–95 (2011)
Amir, R.E., Van Den Veyver, I.B., Wan, M., Tran, C.Q., Francke, U., Zoghbi, H. Y.: Rett syndrome is caused by mutations in X-linked Mecp2, encoding methyl-Cpg-binding protein 2. Nat. Genet. 23, 185–188 (1999)
Baker, S.A., Chen, L., Wilkins, A.D., Yu, P., Lichtarge, O., Zoghbi, H.Y.: An at-hook domain in Mecp2 determines the clinical course of Rett syndrome and related disorders. Cell 152, 984–996 (2013)
Bassani, S., Zapata, J., Gerosa, L., Moretto, E., Murru, L., Passafaro, M.: The neurobiology of X-linked intellectual disability. Neuroscientist 19, 541–552 (2013)
Ben-Shachar, S., Chahrour, M., Thaller, C., Shaw, C.A., Zoghbi, H.Y.: Mouse models of Mecp2 disorders share gene expression changes in the cerebellum and hypothalamus. Hum Mol Genet. 18, 2431–2442 (2009)
Bertulat, B., De Bonis, M.L., Della Ragione, F., Lehmkuhl, A., Milden, M., Storm, C., Jost, K.L., Scala, S., Hendrich, B., D’esposito, M., Cardoso, M.C.: Mecp2 dependent heterochromatin reorganization during neural differentiation of a novel Mecp2-deficient embryonic stem cell reporter line. Plos One 7, E47848 (2012)
Bienvenu, T., Chelly, J.: Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized. Nat. Rev. Genet. 7, 415–426 (2006)
Brero, A., Easwaran, H.P., Nowak, D., Grunewald, I., Cremer, T., Leonhardt, H., Cardoso, M.: Methyl Cpg-binding proteins induce large-scale chromatin reorganization during terminal differentiation. J. Cell Biol. 169, 733–743 (2005)
Calfa, G., Percy, A.K., Pozzo-Miller, L.: Experimental models of Rett syndrome based on Mecp2 dysfunction. Exp. Biol. Med. (Maywood) 236, 3–19 (2011)
Chadwick, L.H., Wade, P.A.: Mecp2 in Rett syndrome: transcriptional repressor or chromatin architectural protein? Curr. Opin. Genet. Dev. 17, 121–125 (2007)
Chahrour, M., Jung, S.Y., Shaw, C., Zhou, X., Wong, S.T., Qin, J., Zoghbi, H.Y.: Mecp2, a key contributor to neurological disease, activates and represses transcription. Science 320, 1224–1229 (2008)
Chen, R.Z., Akbarian, S., Tudor, M., Jaenisch, R.: Deficiency of methyl-Cpg binding protein-2 in Cns neurons results in A Rett-like phenotype in mice. Nat. Genet. 27, 327–331 (2001)
Chen, W.G., Chang, Q., Lin, Y., Meissner, A., West, A.E., Griffith, E.C., Jaenisch, R., Greenberg, M.E.: Derepression of Bdnf transcription involves calcium-dependent phosphorylation of Mecp2. Science 302, 885–889 (2003)
Ebert, D.H., Gabel, H.W., Robinson, N.D., Kastan, N.R., Hu, L.S., Cohen, S., Navarro, A.J., Lyst, M.J., Ekiert, R., Bird, A.P., Greenberg, M.E.: Activity-dependent phosphorylation of Mecp2 threonine 308 regulates interaction with Ncor. Nature 499, 341–345 (2013)
Gabel, H.W., Kinde, B., Stroud, H., Gilbert, C.S., Harmin, D.A., Kastan, N.R., Hemberg, M., Ebert, D.H., Greenberg, M.E.: Disruption of DNA-methylation-dependent long gene repression in Rett syndrome. Nature 522, 89–93 (2015)
Guo, J.U., Su, Y., Shin, J.H., Shin, J., Li, H., Xie, B., Zhong, C., Hu, S., Le, T., Fan, G., Zhu, H., Chang, Q., Gao, Y., Ming, G.L., Song, H.: Distribution, recognition and regulation of non-Cpg methylation in the adult mammalian brain. Nat. Neurosci. 17, 215–222 (2014)
Guy, J., Hendrich, B., Holmes, M., Martin, J.E., Bird, A.: A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet. 27, 322–326 (2001)
Guy, J., Cheval, H., Selfridge, J., Bird, A.: The role of Mecp2 in the brain. Ann. Rev. Cell Dev. Biol. 27, 631–652 (2011)
Horike, S., Cai, S., Miyano, M., Cheng, J.F., Kohwi-Shigematsu, T.: Loss of silent-chromatin looping and impaired imprinting of Dlx5 in Rett syndrome. Nat. Genet. 37, 31–40 (2005)
Kinde, B., Gabel, H.W., Gilbert, C.S., Griffith, E.C., Greenberg, M.E.: Reading the unique DNA methylation landscape of the brain: non-Cpg methylation, hydroxymethylation, and Mecp2. Proc. Natl. Acad. Sci. USA 112, 6800–6806 (2015)
Klose, R., Bird, A.: Molecular biology. Mecp2 repression goes nonglobal. Science 302, 793–795 (2003)
Lewis, J.D., Meehan, R.R., Henzel, W.J., Maurer-Fogy, I., Jeppesen, P., Klein, F., Bird, A.: Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69, 905–914 (1992)
Li, W., Pozzo-Miller, L.: Bdnf deregulation in Rett syndrome. Neuropharmacology 76, 737–746 (2013)
Lister, R., Mukamel, E.A., Nery, J.R., Urich, M., Puddifoot, C.A., Johnson, N.D., Lucero, J., Huang, Y., Dwork, A.J., Schultz, M.D., Yu, M., Tonti-Filippini, J., Heyn, H., Hu, S., Wu, J.C., Rao, A., Esteller, M., He, C., Haghighi, F.G., Sejnowski, T.J., Behrens, M.M., Ecker, J.R.: Global epigenomic reconfiguration during mammalian brain development. Science 341, 1237905 (2013)
Lyst, M.J., Ekiert, R., Ebert, D.H., Merusi, C., Nowak, J., Selfridge, J., Guy, J., Kastan, N.R., Robinson, N.D., De Lima Alves, F., Rappsilber, J., Greenberg, M.E., Bird, A.: Rett syndrome mutations abolish the interaction of Mecp2 with the Ncor/Smrt co-repressor. Nat. Neurosci. 16, 898–902 (2013)
Martinowich, K., Hattori, D., Wu, H., Fouse, S., He, F., Hu, Y., Fan, G., Sun, Y.E.: DNA methylation-related chromatin remodeling in activity-dependent Bdnf gene regulation. Science 302, 890–893 (2003)
Maunakea, A.K., Chepelev, I., Cui, K., Zhao, K.: Intragenic DNA methylation modulates alternative splicing by recruiting Mecp2 to promote exon recognition. Cell Res. 23, 1256–1269 (2013)
Maxwell, S.S., Pelka, G.J., Tam, P.P., El-Osta, A.: Chromatin context and ncRNA highlight targets of Mecp2 in brain. RNA Biol. 10, 1741–1757 (2013)
Meehan, R.R., Lewis, J.D., Bird, A.P.: Characterization of Mecp2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res. 20, 5085–5092 (1992)
Mellen, M., Ayata, P., Dewell, S., Kriaucionis, S., Heintz, N.: Mecp2 binds to 5hmc enriched within active genes and accessible chromatin in the nervous system. Cell 151, 1417–1430 (2012)
Muotri, A.R., Marchetto, M.C., Coufal, N.G., Oefner, R., Yeo, G., Nakashima, K., Gage, F.H.: L1 Retrotransposition in neurons is modulated by Mecp2. Nature 468, 443–446 (2010)
Nan, X., Cross, S., Bird, A.: Gene Silencing by methyl-Cpg-binding proteins. Novartis Found Symp. 214, 6–16 (1998); Discussion 16–21, 46–50
Nguyen, M.V., Du, F., Felice, C.A., Shan, X., Nigam, A., Mandel, G., Robinson, J. K., Ballas, N.: Mecp2 is critical for maintaining mature neuronal networks and global brain anatomy during late stages of postnatal brain development and in the mature adult brain. J. Neurosci. 32, 10021–34 (2012)
Petazzi, P., Sandoval, J., Szczesna, K., Jorge, O.C., Roa, L., Sayols, S., Gomez, A., Huertas, D., Esteller, M. Dysregulation of the long non-coding RNA transcriptome in a Rett syndrome mouse model. RNA Biol. 10, 1197–1203 (2013)
Rett, A.: On A unusual brain atrophy syndrome in hyperammonemia in childhood. Wien Med Wochenschr 116, 723–726 (1966)
Rinn, J.L., Kertesz, M., Wang, J.K., Squazzo, S.L., Xu, X., Brugmann, S.A., Goodnough, L.H., Helms, J.A., Farnham, P.J., Segal, E., Chang, H.Y.: Functional demarcation of active and silent chromatin domains in human Hox loci by noncoding RNAs. Cell 129, 1311–1323 (2007)
Shahbazian, M., Young, J., Yuva-Paylor, L., Spencer, C., Antalffy, B., Noebels, J., Armstrong, D., Paylor, R., Zoghbi, H.: Mice with truncated Mecp2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35, 243–254 (2002)
Skene, P.J., Illingworth, R.S., Webb, S., Kerr, A.R., James, K.D., Turner, D.J., Andrews, R., Bird, A.P.: Neuronal Mecp2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol. Cell 37, 457–468 (2010)
Sugino, K., Hempel, C.M., Okaty, B.W., Arnson, H.A., Kato, S., Dani, V.S., Nelson, S.B.: Cell-type-specific repression by methyl-Cpg-binding protein 2 is biased toward long genes. J. Neurosci. 34, 12877–12883 (2014)
Tate, P., Skarnes, W., Bird, A.: The methyl-Cpg binding protein Mecp2 is essential for embryonic development in the mouse. Nat. Genet. 12, 205–208 (1996)
Wan, M., Zhao, K., Lee, S.S., Francke, U.: Mecp2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome. Hum. Mol. Genet. 10, 1085–1092 (2001)
Wang, K.C., Chang, H.Y.: Molecular mechanisms of long noncoding RNAs. Mol. Cell 43, 904–914 (2011)
Zhou, H.L., Luo, G., Wise, J.A., Lou, H.: Regulation of alternative splicing by local histone modifications: potential roles for RNA-guided mechanisms. Nucleic Acids Res. 42, 701–713 (2014)
Acknowledgements
The authors gratefully acknowledge Epigenomics Flagship Project EPIGEN MIUR-CNR and Associazione Italiana Sindrome di Rett. FS is recipient of a Neuromed fellowship.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Vacca, M., Ragione, F.D., Tripathi, K.P., Scalabrì, F., D’Esposito, M. (2015). MECP2: A Multifunctional Protein Supporting Brain Complexity. In: Zazzu, V., Ferraro, M., Guarracino, M. (eds) Mathematical Models in Biology. Springer, Cham. https://doi.org/10.1007/978-3-319-23497-7_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-23497-7_8
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-23496-0
Online ISBN: 978-3-319-23497-7
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)